Cargando…
Nebulized Nitroglycerin for Coronavirus Disease 2019–Associated Acute Respiratory Distress Syndrome: A Case Report
We present a case where nitroglycerin tablets dissolved in saline and intravenous nitroglycerin solution were nebulized as surrogates for inhaled nitric oxide (iNO) after our iNO supply was depleted during the coronavirus disease 2019 (COVID-19) surge in New York. We gave this treatment to a COVID-1...
Autores principales: | Daxon, Benjamin T., Lark, Erin, Matzek, Luke J., Fields, Amanda R., Haselton, Kyle J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908862/ https://www.ncbi.nlm.nih.gov/pubmed/33560642 http://dx.doi.org/10.1213/XAA.0000000000001376 |
Ejemplares similares
-
Nebulized nitroglycerin in the emergency department
por: Ulloa, Nicolas A., et al.
Publicado: (2023) -
COVID-19 Acute Respiratory Distress Syndrome and Pulmonary Embolism: A Case Report of Nebulized Nitroglycerin and Systemic Thrombolysis For Right Ventricular Failure
por: Karfunkle, Benjamin, et al.
Publicado: (2021) -
Breath-Synchronized Nebulized Surfactant in a Porcine Model of Acute Respiratory Distress Syndrome
por: DiBlasi, Robert M., et al.
Publicado: (2021) -
2021 Acute Respiratory Distress Syndrome Update, With Coronavirus Disease 2019 Focus
por: Welker, Carson, et al.
Publicado: (2022) -
COVID-19-associated acute respiratory distress syndrome (C-ARDS): Inhaled nitroglycerin could be an efficient pulmonary vasodilator
por: Daunaria, Deepak K., et al.
Publicado: (2023)